Home » Pharma Blog Watch
Pharma Blog Watch
Never Mind FDA, States Are Crafting Biosimilar Laws (Pharmalot Blog)
The FDA may not have approved a biosimilar yet or decided whether a biosimilar is interchangeable with a brand biologic, but this is not stopping some state legislatures from considering bills that would allow substitution, blogger Ed Silverman writes. Currently, three states — Virginia, Pennsylvania and Illinois — have legislation in the works that may gain momentum this year.
The FDA may not have approved a biosimilar yet or decided whether a biosimilar is interchangeable with a brand biologic, but this is not stopping some state legislatures from considering bills that would allow substitution, blogger Ed Silverman writes. Currently, three states — Virginia, Pennsylvania and Illinois — have legislation in the works that may gain momentum this year.
Upcoming Events
-
02May
-
07May
-
14May
-
23May
-
30May